Natco Pharma share rose after the company announced that Mylan Pharmaceuticals Inc & Novo Nordisk have reached a settlement of the US patent litigation related to generic Ozempic (Semaglutide)
The uptick in SEPC share price came after the company announced that it has secured an order of Rs 182.56 crore.
The Nifty50 broad-based index is reviewed twice a year based on six-month data ending January 31 and July 31.
Ambuja Cements (up 1.4%) Aurobindo Pharma (up 4.8%) and Bosch (up 2.4%) also rose, despite exclusion from the index